HEARTBEAM INC (BEAT)       4.83  +0.01 (+0.21%)

4.83  +0.01 (+0.21%)

US42238H1086 - Common Stock - After market: 4.75 -0.08 (-1.66%)


Fundamental Rating

3

Overall BEAT gets a fundamental rating of 3 out of 10. We evaluated BEAT against 222 industry peers in the Health Care Equipment & Supplies industry. BEAT has a great financial health rating, but its profitability evaluates not so good. BEAT is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

1

The Piotroski-F score of BEAT is 5.00. This is a neutral score and indicates average health and profitability for BEAT.
BEAT has negative profitability rations, so we won't be analyzing them here.

BEAT's Return On Assets of -169.89% is worse than the rest of the industry. The industry average Return On Assets is -19.67%. 97% of the industry peers have a better Return On Assets.
VS Industry

ROA (-169.89%) VS Industry: 3% outperformed.

-771.54
117.69

Valuation

Valuation Rating

1

When comparing the current price to the book value of BEAT, we can conclude it is valued correctly. It is trading at 6.73 times its book value.
BEAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BEAT. No positive earnings are expected for the next year.
Compared to an average industry price book ratio of 2.57, BEAT is valued more expensive than its industry peers. 80% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (6.73) VS Industry: 20% outperformed.

1,084.59
0.07

Growth

Growth Rating

0

The earnings per share for BEAT have decreased strongly by -206.16% in the last year.

The Earnings Per Share is expected to decrease by -10.83% on average over the next 5 years. This is quite bad

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -206.16% -229.49% -56.89% 6.42% -10.83%
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

8

BEAT has a Current Ratio of 7.16. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 3.63.
BEAT has a Quick Ratio of 7.16. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.
BEAT is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 2.85. BEAT has a better rating than 81% of its industry peers.

The Debt to Equity ratio of BEAT is way better than the industry averages.
BEAT has an Altman-Z score of 15.90. This indicates that BEAT is financially healthy and little risk of bankruptcy at the moment.
BEAT has one of the better Altman-Z scores in its industry. It is much better than the industry average of 1.89. BEAT has a better score than 92% of its industry peers.
BEAT has a Piotroski-F score of 5.00. This indicates an average health and profitability for BEAT.
VS Industry

Debt/Equity (0) VS Industry: 68% outperformed.

336.87
0.00

Quick Ratio (7.16) VS Industry: 81% outperformed.

0.06
31.22

Current Ratio (7.16) VS Industry: 77% outperformed.

0.13
31.22

Altman-Z (15.9) VS Industry: 92% outperformed.

-105.06
72.93

Dividend

Dividend Rating

0

BEAT does not give a dividend.

BEAT Daily chart

HEARTBEAM INC4.83

NASDAQ:BEAT (12/6/2022, 6:29:32 PM)+0.01 (+0.21%)

After market: 4.75 -0.08 (-1.66%)

Chartmill FA Rating
GICS Sector Health Care
GICS IndustryGroup Health Care Equipment & Services
GICS Industry Health Care Equipment & Supplies
Earnings (Last) 11-10 2022-11-10/amc Earnings (Next) N/A N/A
Ins Owners 17.84% Inst Owners 0.11%
Market Cap 38.64M Analysts 82.5
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S N/A P/B 6.73
EV/EBITDA N/A
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y -206.16% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -37.5%
EPS Next Y -229.49% EPS Next 2Y -56.89%
EPS Next 3Y 6.42% EPS Next 5Y -10.83%
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 7.16 Quick Ratio 7.16
Altman-Z 15.9 F-Score 5
Debt/Equity 0 WACC N/A
ROIC/WACC N/A
Profitability
ROA -169.89% ROE N/A
ROICexgc N/A ROIC N/A
PM N/A OM N/A
Asset Turnover N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA